Product Offerings

LifeNet Health

LifeNet HealthSaving Lives • Restoring Health • Giving Hope

Saving Lives, Restoring Health and Giving Hope isn’t just our mission; it has been our sole motivation since 1982. That commitment has driven us to become a world leader in allograft bio-implants, with an unmatched safety record that makes us the most-trusted partner in the field. It also has focused our efforts to aggressively innovate bio-implant technologies and cellular therapies and to lead in regenerative medicine.

Vascular

Allograft Bio-Implants for Vascular Procedures

AngioGRAFT® cryopreserved vascular allografts are the safe choice for managing vascular reconstruction. In peripheral bypass surgery, LifeNet Health femoral and saphenous vessel allografts provide an effective clinical option. When bypassing stenosed vascular segments in the treatment of peripheral vascular disease, or in CABG procedures, acceptable native vessels are often not available. LifeNet Health cryopreserved vessels are a natural solution for peripheral bypass procedures and reconstruction. When confronting failing A/V access grafts, consider LifeNet Health allografts as an ideal natural solution for dialysis access and the replacement of infected synthetic dialysis grafts.

LifeNet Femoral Vessel
Femoral Vessels
Description

AngioGRAFT® Femoral Artery and Vein

Benefits

• Human tissue-most closely resembles native tissue
• Resistance to infection
• Vein allografts are an alternative conduit for patients lacking available autogenous veins

Clinical Application

• Patients in whom an autologous fistula is not possible
• Replacing infected AV access grafts or in patients who are at risk of AV access infections
• Patients with a limited number of AV access sites
• Peripheral vascular disease


LifeNet Saphenous Vein
Saphenous Vein
Description

AngioGRAFT® Cryopreserved Saphenous Vein

Benefits

• Human tissue-most closely resembles native tissue
• Resistance to infection
• Vein allografts are an alternative conduit for patients lacking available autogenous veins

Clinical Application

• Peripheral vascular disease
• CABG
• Patients with infected fields or at risk of infection
• AV access


LifeNet Aortoiliac Artery
Aortoiliac Artery
Description

A safe and efficacious alternative to synthetic grafts, in abdominal aortoiliac procedures.

Benefits

• Allograft tissue most closely resembles the patient’s native tissue
• Convenient: Available in 3 configurations, and measured in both flaccid and pressurized diameter sizing
• Safety: Allografts offer a high resistance to infection1, 2

Clinical Application

• Infected Synthetic Graft Replacement
• Trauma
• Mycotic Aneurysm
• Aortoenteric Fistula


Cardiac

Allograft Bio-Implants for Cardiac Procedures

Suitable for a wide variety of complex congenital heart defects, as well as for adults with extensive valvular disease. The CardioGRAFT® line of tissue grafts offers heart valves, repair grafts, conduits and decellularized tissue grafts with Matracell® decellularization technology.

LifeNet Aortic Heart Valve
Aortic Heart Valve
Description

CardioGRAFT® Aortic Heart Valve

Benefits

• No anticoagulation therapy required
• Exceptionally good hemodynamic performance
• No immunosuppressive therapy needed
• Non-thrombogenic
• Non-hemolytic
• Human tissue - most closely resembles native tissue
• High resistance to infection

Clinical Application

• Left side/aortic reconstruction
• Aortic stenosis/atresia
• Hypoplastic left heart
• Repair of RVOTs (Right Ventricular Outflow Tract)


LifeNet Pulmonary Heart Valve
Pulmonary Heart Valve
Description

CardioGRAFT® Pulmonary Heart Valve

Benefits

• No Anticoagulation therapy required
• Non-thrombogenic
• Non-hemolytic
• No immunosuppressive therapy required
• Human tissue - most closely resembles native tissue
• High resistance to infection

Clinical Application

• Right side/pulmonary reconstructions
• Hypoplastic left heart (modified Fontan)
• Ross procedure
• Truncus arteriosus
• Pulmonary atresia
• Single ventricle/double outlet (Fontan)
• Pulmonary root stenosis


LifeNet Ascending Aorta (non-valved) Conduit
Ascending Aorta (non-valved) Conduit
Description

CardioGRAFT® Ascending Aorta non-valved

Benefits

• Non-thrombogenic
• Non-hemolytic
• No immunosuppressive therapy required
• Human tissue - most closely resembles native tissue
• High resistance to infection
• No anticoagulation therapy required

Clinical Application

• Conduit repair


LifeNet Pulmonary Artery (non-valved) Conduit
Pulmonary Artery (non-valved) Conduit
Description

CardioGRAFT® Pulmonary Artery (non valved)

Benefits

• No Anticoagulation therapy required
• Non-thrombogenic
• Non-hemolytic
• No immunosuppressive therapy required
• Human tissue - most closely resembles native tissue
• High resistance to infection

Clinical Application

• Right side/pulmonary reconstructions
• Tetralogy of Fallot
• Pulmonary atresia
• Single ventricle/double outlet (Fontan)
• Truncus arteriosus
• Pulmonary root stenosis


LifeNet Thoracic Aorta Conduit
Thoracic Aorta Conduit
Description

CardioGRAFT® Thoracic Aorta

Benefits

• No Anticoagulation therapy required
• Non-thrombogenic
• Non-hemolytic
• No immunosuppressive therapy required
• Human tissue - most closely resembles native tissue
• High resistance to infection

Clinical Application

• Infected descending aorta
• Conduit repair
• Extra-cardiac shunt


Hemi-Pulmonary Artery Repair Graft
Hemi-Pulmonary Artery Repair Graft
Description

CardioGRAFT® Hemi-Pulmonary Artery

Benefits

• No Anticoagulation therapy required
• Non-thrombogenic
• Non-hemolytic
• No immunosuppressive therapy required
• Human tissue - most closely resembles native tissue
• High resistance to infection

Clinical Application

• Tetralogy of Fallot
• Pulmonary atresia
• Single ventricle/double outlet (Fontan)
• Truncus arteriosus
• Transposition of great vessels
• Hypoplastic left heart (modified Fontan)
• Aortic stenosis/atresia


Mono Cusp Patch Repair Graft
Mono Cusp Patch Repair Graft
Description

CardioGRAFT® Mono Cusp Patch

Benefits

• Single valved section of main pulmonary trunk
• Original annulus diameter
• Length and width measured in centimeters
• No minimum or maximum width

Clinical Application

• Tetralogy of Fallot
• RVOT/root enlargement procedures


Pulmonary Patch Repair Graft
Pulmonary Patch Repair Graft
Description

CardioGRAFT® Pulmonary Patch section produced from the main pulmonary artery

Benefits

• No anticoagulation therapy required
• Non-thromogenic
• Non-hemolytic
• No immunosuppressive therapy required
• Human tissue - most closely resembles native tissue
• High resistance to infection

Clinical Application

• Right side/pulmonary reconstructions
• Tetralogy of Fallot
• Single ventricle/double outlet (Fontan)
• Truncus arterious; ASD/VSD repair


Decellularized Pulmonary Patch Repair Graft
Decellularized Pulmonary Patch Repair Graft
Description

CardioGRAFT® Decellularized Pulmonary Patch with Matracell®

Clinical Application

• RVOT Repair


Decellularized Hemi-Pulmonary Artery Repair Graft
Decellularized Hemi-Pulmonary Artery Repair Graft
Description

CardioGRAFT® Decellularized Hemi-Pulmonary Artery with Matracell®

Benefits

• Matracell safely removes donor cells and DNA without sacrificing the biomechanical strength of the allograft bio-implant

Clinical Application

• RVOT Repair


DASI Simulations

Dasi Simulations has created the first FDA-cleared application of artificial intelligence for complex cardiac surgery planning

AI Simulations for Better Patient Outcomes


Precision TAVI™

Dasi's Flagship AI-Powered Simulation
Precision TAVI™

DASI Portal & Mobile Application

Newly Launched
The DASI Portal & Mobile Application

DASI Dimensions

COMING SOON!
DASI Dimensions

DASI Simulation's suite of technologies are not just tools, they're catalysts for better patient outcomes. The AI-powered simulations provide clinicians with advanced simulation capabilities, automatic assessments, and explainable AI. DASI Simulations is setting the new standard in healthcare.

Products Overview

DASI Simulations is at the forefront of innovation, providing cutting-edge artificial intelligence-driven computational predictive modeling-based decision support products. Their mission is to empower physicians and heart teams with the tools they need to predict, visualize, and optimize patient care, all while streamlining workflows and enhancing efficiency.

Key Features of their AI Solutions:

AI Solutions
Predictive Visualization

Predictive Visualization
Our solution enables interventional cardiologists to predict and visualize the intricate interaction between various devices and a patient's unique anatomy. This predictive capability frees up valuable time by eliminating the need for time-consuming assessments.

Automated AI-Based Assessments

Automated AI-Based Assessments
DASI Simulation's fully automated AI-based assessments ensure a level of accuracy, repeatability, and reproducibility that is unmatched. This not only enhances precision in medical assessments but also accelerates decision-making for heart teams.

Cloud-Based AI Platform

Cloud-Based AI Platform
With a simple click, our solution begins with the upload of patient CT angiograms to our secure cloud server. Propelled by proprietary technology, our AI platform runs simulations across comprehensive scenarios, providing interactive content to guide physicians and heart teams towards optimal decisions.

Personalized Support

Personalized Support
DASI Simulations goes beyond technology by offering highly qualified biomedical engineers who perform quality checks and are available 24/7 for personalized consultations with heart teams. This ensures that every decision is backed by expert insights.


DASI Simulations provides advanced artificial intelligence-driven computational predictive modeling-based decision support products. Our solution allows physicians to predict and visualize the interaction between various devices and the patient’s unique anatomy while freeing up their time from making time-consuming assessments. DASI Simulation’s fully automated AI-based measurements are highly accurate, repeatable, and reproducible while speeding up the workflow for heart teams to reach optimal decisions quicker.

DASI’s solution starts with a simple click to upload patient’s CT angiograms to our secure cloud server. Based on proprietary technology, our cloud-based AI platform runs simulations spanning comprehensive scenarios for each patient and presents the results to the physician and heart teams as interactive content guiding them to reach the optimal decision. Lastly, DASI’s highly qualified biomedical engineers perform quality checks and are available 24/7 to consult with the heart team for personalized support.

DASI Simulations empowers every heart team with critical insights guaranteeing the identification of the best possible care for individual patients customized to their unique circumstances. One surgery at a time, our technology helps avoid complications, repeated interventions, and saves billions in unnecessary costs from preventable complications.

Patient-Specific Pre-Surgical Planning

Reducing TAVR Complications

Hindsight is always 20/20 when it comes to complications during or after heart valve surgery. Almost all device-related complications are because of an imperfect interaction between the implantable device (e.g. an artificial heart valve or clip) and the patient’s unique anatomy. These imperfect interactions result in abnormal stresses on the heart tissues as well as abnormal blood flow which in turn manifest as mild to fatal adverse outcomes including failure to provide adequate relief to the patient’s symptoms. In hindsight after complications, physicians know how they would have handled the case differently. A recent report from the American College of Cardiology describes such complications as impacting the majority of patients and hospitals.

Currently, there are no tools available for physicians to predict and visualize the interaction between various devices and the patient’s unique anatomy before the procedure. Such tools that provide foresight are necessary to avoid complications such as ruptures, obstructions, leakages, rhythm problems, and clots on the valve. Instead, the tools currently available to pre-plan these complex procedures involve manual mark-up of dimensions and identification of cardiac structures from medical images such as CT scans. Surprisingly, even this critical step is more often performed by sales representatives due to its time-consuming nature and is prone to human error.

The problem described above is hindering the ability of physicians and heart teams to make optimal decisions starting with the decision between trans-catheter vs open heart surgery followed by optimal selection of the device, its optimal positioning and customization. Currently, sub-optimal decisions are made due to the lack of predictive quantitative risk assessment tools. The combination of human error from time-consuming measurements and subjective decisions significantly contribute to the prevalence of less than average performance and billions in costs to the healthcare system.

The statistics are not good and nobody — especially your loved one — should become a statistic. We are here to help.

Marquet Getinge Group

Marquet Getinge Group Hemashield Vascular Grafts
Hemashield Vascular Grafts
Marquet Getinge Group VasoView Endoscopic Vein Harvesting
VasoView Endoscopic Vein Harvesting
Marquet Getinge Group Cardiac Stabilizers & Positioners
Cardiac Stabilizers & Positioners
Marquet Getinge Group Heart String Aortic Closure Device
Heart String Aortic Closure Device

Edwards Lifesciences

Edwards Lifesciences Cardiac Cannulation
Cardiac Cannulation
  • Arterial
  • Venous
  • Femoral
  • Cardioplegia